{"id":"https://openalex.org/W7224852385","doi":"https://doi.org/10.5281/zenodo.23804159","title":"FORMULATION AND IN-VITRO EVALUATION OF CELECOXIB-LOADED NIOSOMAL MATRIX-TYPE TRANSDERMAL PATCHES FOR THE MANAGEMENT OF OSTEOARTHRITIS","display_name":"FORMULATION AND IN-VITRO EVALUATION OF CELECOXIB-LOADED NIOSOMAL MATRIX-TYPE TRANSDERMAL PATCHES FOR THE MANAGEMENT OF OSTEOARTHRITIS","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7224852385","doi":"https://doi.org/10.5281/zenodo.23804159"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23804159","doi":"https://doi.org/10.5281/zenodo.23804159","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23804159","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.23804159","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160231318","display_name":"Pandian C.1*, Praveen Kumar D.1, Gowtham A.2, Pooja B.2, Gunaseelan M.2, Keerthana M.2","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Pandian C.1*, Praveen Kumar D.1, Gowtham A.2, Pooja B.2, Gunaseelan M.2, Keerthana M.2","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5160231318"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.83780182,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9810000061988831},{"id":"https://openalex.org/keywords/niosomes","display_name":"niosomes","score":0.9800000190734863},{"id":"https://openalex.org/keywords/transdermal-patch","display_name":"transdermal patch","score":0.8840000033378601},{"id":"https://openalex.org/keywords/matrix-type-patch","display_name":"matrix-type patch","score":0.6930000185966492},{"id":"https://openalex.org/keywords/osteoarthritis","display_name":"osteoarthritis","score":0.9909999966621399},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.7860000133514404},{"id":"https://openalex.org/keywords/hpmc-k100","display_name":"HPMC K100","score":0.8809999823570251},{"id":"https://openalex.org/keywords/pvp-k30","display_name":"PVP K30","score":0.9980000257492065},{"id":"https://openalex.org/keywords/higuchi-kinetics","display_name":"Higuchi model","score":0.7080000042915344},{"id":"https://openalex.org/keywords/anomalous-transport","display_name":"anomalous transport","score":0.5580000281333923},{"id":"https://openalex.org/keywords/thin-film-hydration","display_name":"thin-film hydration","score":0.6579999923706055},{"id":"https://openalex.org/keywords/span-60","display_name":"Span 60","score":0.6700000166893005},{"id":"https://openalex.org/keywords/cholesterol","display_name":"cholesterol","score":0.9369999766349792},{"id":"https://openalex.org/keywords/physicochemical-characterization","display_name":"physicochemical characterization","score":0.5879999995231628},{"id":"https://openalex.org/keywords/patch-formulation-optimization","display_name":"patch formulation optimization","score":0.43700000643730164},{"id":"https://openalex.org/keywords/bcs-class-ii","display_name":"BCS class II","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.8513000011444092},{"id":"https://openalex.org/C72918618","wikidata":"https://www.wikidata.org/wiki/Q1993211","display_name":"Niosome","level":4,"score":0.8213000297546387},{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.5845999717712402},{"id":"https://openalex.org/C11432220","wikidata":"https://www.wikidata.org/wiki/Q1975334","display_name":"Dispersity","level":2,"score":0.5223000049591064},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4909000098705292},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45350000262260437},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.4223000109195709},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.420199990272522},{"id":"https://openalex.org/C169222746","wikidata":"https://www.wikidata.org/wiki/Q4116558","display_name":"Factorial experiment","level":2,"score":0.4169999957084656},{"id":"https://openalex.org/C2776164576","wikidata":"https://www.wikidata.org/wiki/Q62736","display_name":"Osteoarthritis","level":3,"score":0.4050999879837036},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40389999747276306},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.3840999901294708},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.34769999980926514},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3393000066280365},{"id":"https://openalex.org/C2775842315","wikidata":"https://www.wikidata.org/wiki/Q1145270","display_name":"Transdermal patch","level":3,"score":0.3382999897003174},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.337799996137619},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.3239000141620636},{"id":"https://openalex.org/C202271784","wikidata":"https://www.wikidata.org/wiki/Q189218","display_name":"Molar","level":2,"score":0.3237999975681305},{"id":"https://openalex.org/C2777937549","wikidata":"https://www.wikidata.org/wiki/Q5464303","display_name":"Folding endurance","level":4,"score":0.31709998846054077},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.30059999227523804},{"id":"https://openalex.org/C106487976","wikidata":"https://www.wikidata.org/wiki/Q685816","display_name":"Matrix (chemical analysis)","level":2,"score":0.28369998931884766},{"id":"https://openalex.org/C2776915481","wikidata":"https://www.wikidata.org/wiki/Q1066302","display_name":"Entrapment","level":2,"score":0.2818000018596649},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.2800999879837036},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2766000032424927},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.2651999890804291},{"id":"https://openalex.org/C138651985","wikidata":"https://www.wikidata.org/wiki/Q186249","display_name":"Pharmaceutics","level":2,"score":0.263700008392334},{"id":"https://openalex.org/C3019981671","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Immediate release","level":2,"score":0.26330000162124634},{"id":"https://openalex.org/C104628117","wikidata":"https://www.wikidata.org/wiki/Q3964828","display_name":"Sonication","level":2,"score":0.25690001249313354},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.2508000135421753}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23804159","doi":"https://doi.org/10.5281/zenodo.23804159","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23804159","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23804160","doi":"https://doi.org/10.5281/zenodo.23804160","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23804160","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23804159","doi":"https://doi.org/10.5281/zenodo.23804159","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23804159","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1828902177","https://openalex.org/W7099279311","https://openalex.org/W7164835443","https://openalex.org/W4400302622","https://openalex.org/W4411382581","https://openalex.org/W2044600270","https://openalex.org/W2231669397","https://openalex.org/W2183357014","https://openalex.org/W193118289","https://openalex.org/W7171169953"],"abstract_inverted_index":{"Celecoxib,":[0],"a":[1,15,52,95,102,108,140,211,237,260,265],"selective":[2],"cyclo-oxygenase-2":[3],"(COX-2)":[4],"inhibitor":[5],"widely":[6],"prescribed":[7],"for":[8,117,269],"the":[9,68,85,90,126,151,216,230],"symptomatic":[10],"management":[11,276],"of":[12,56,99,105,111,153,200,244,272],"osteoarthritis,":[13],"is":[14,264],"Biopharmaceutics":[16],"Classification":[17],"System":[18],"(BCS)":[19],"Class":[20],"II":[21],"drug":[22,58,192,224],"whose":[23],"poor":[24],"aqueous":[25],"solubility":[26],"and":[27,44,60,75,83,107,114,132,164,197,250,277,283],"cardio-gastrointestinal":[28],"liabilities":[29],"on":[30],"chronic":[31],"oral":[32],"dosing":[33],"limit":[34],"its":[35],"clinical":[36],"utility.":[37],"The":[38,157],"present":[39],"study":[40],"aimed":[41],"to":[42],"formulate":[43],"evaluate":[45],"celecoxib-loaded":[46],"niosomal":[47],"matrix-type":[48,261],"transdermal":[49,121,262,270],"patches":[50,122],"as":[51,135],"non-invasive":[53],"alternative":[54],"capable":[55],"sustaining":[57],"release":[59],"reducing":[61],"systemic":[62],"exposure.":[63],"Niosomes":[64],"were":[65,123],"prepared":[66,124],"by":[67,125],"thin-film":[69],"hydration":[70],"technique":[71],"using":[72,129],"Span":[73],"60":[74],"cholesterol":[76],"at":[77],"three":[78],"molar":[79],"ratios":[80],"(1:1:1,":[81],"1:2:1":[82],"1:2:2);":[84],"1:1:1":[86],"formulation":[87],"(F1)":[88],"showed":[89],"highest":[91],"entrapment":[92,222],"efficiency":[93],"(93.24%),":[94],"mean":[96],"particle":[97],"size":[98],"616.0":[100],"nm,":[101],"polydispersity":[103],"index":[104],"0.315":[106],"zeta":[109],"potential":[110],"\u221232.7":[112],"mV,":[113],"was":[115],"selected":[116],"patch":[118,159,214,263],"fabrication.":[119],"Matrix-type":[120],"solvent-casting":[127],"method":[128],"HPMC":[130,162],"K100":[131,163],"PVP":[133,166],"K30":[134],"film-forming":[136],"polymers,":[137],"optimised":[138,158],"through":[139],"3\u00b2":[141],"factorial":[142],"design":[143],"(nine":[144],"batches,":[145],"F1\u2013F9).":[146],"Fourier-transform":[147],"infrared":[148],"spectroscopy":[149],"confirmed":[150],"absence":[152],"significant":[154],"drug\u2013excipient":[155],"interaction.":[156],"(F3,":[160],"high":[161,165],"K30)":[167],"exhibited":[168],"satisfactory":[169],"physicomechanical":[170],"properties":[171],"(weight":[172],"192.6":[173],"\u00b1":[174,179,185,190,195],"2.1":[175],"mg,":[176],"thickness":[177],"0.53":[178],"0.01":[180],"mm,":[181],"folding":[182],"endurance":[183],"290":[184],"6,":[186],"surface":[187],"pH":[188],"5.86":[189],"0.04,":[191],"content":[193],"98.40":[194],"0.45%)":[196],"released":[198,209],"71.0%":[199],"celecoxib":[201,273],"over":[202,215],"12":[203],"h":[204],"in-vitro,":[205],"compared":[206],"with":[207,236],"85%":[208],"from":[210],"plain":[212],"(non-vesicular)":[213],"same":[217],"period,":[218],"confirming":[219],"that":[220,256],"vesicular":[221],"sustained":[223],"release.":[225],"Release":[226],"data":[227],"best":[228],"fitted":[229],"Higuchi":[231],"model":[232],"(R\u00b2":[233],"=":[234,241],"0.992),":[235],"Korsmeyer\u2013Peppas":[238],"exponent":[239],"(n":[240],"0.68)":[242],"indicative":[243],"non-Fickian":[245],"(anomalous)":[246],"transport":[247],"combining":[248],"diffusion":[249],"polymer":[251],"relaxation.":[252],"These":[253],"findings":[254],"suggest":[255],"incorporating":[257],"niosomes":[258],"into":[259],"promising":[266],"controlled-release":[267],"approach":[268],"delivery":[271],"in":[274,284],"osteoarthritis":[275],"warrants":[278],"further":[279],"ex":[280],"vivo":[281,285],"permeation":[282],"evaluation.":[286]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2026-10-31T00:00:00"}